METTL3 rs1061026: What Your Genotype Means
The rs1061026 variant is a genetic polymorphism located in the METTL3 gene, which encodes a key enzyme involved in m6A RNA methylation. Research has explored its statistical association with breast cancer susceptibility and cellular RNA modification processes.
What each genotype means
Baseline breast cancer risk
This is the most common genotype observed in many populations. Research indicates that individuals with this genotype do not carry the specific genetic variation associated with reduced breast cancer susceptibility identified in recent studies of Chinese women.
This is the major allele genotype and is the most frequently observed configuration in most global populations.
Reduced breast cancer susceptibility
Carrying one copy of the G allele is associated with a statistically significant reduction in breast cancer susceptibility in studies of Chinese women. This variant is located in the METTL3 gene, which plays a role in RNA modification processes that may influence cancer development.
This heterozygous genotype is found at varying frequencies, with higher prevalence observed in East Asian populations compared to other ancestral groups.
Reduced breast cancer susceptibility
Carrying two copies of the G allele is associated with a reduced susceptibility to breast cancer in research involving Chinese women. This genotype suggests a potential protective effect related to the regulation of METTL3-mediated RNA methylation, though these findings are specific to certain populations and require further study.
This homozygous genotype is less common than the heterozygous state and is primarily documented in East Asian cohorts.
What is the METTL3 rs1061026 Variant?
The rs1061026 variant is a single nucleotide polymorphism (SNP) found within the METTL3 gene. METTL3 stands for methyltransferase-like 3, a protein that functions as a primary 'writer' in the process of N6-methyladenosine (m6A) modification. This modification is a chemical change that occurs on RNA molecules, influencing how they are processed, stabilized, and translated into proteins. Because METTL3 is essential for these regulatory functions, variations in its genetic sequence are of interest to researchers studying how cells maintain normal function versus how they might transition into disease states. The rs1061026 variant represents a specific site where individuals may differ in their DNA sequence, potentially affecting the efficiency or regulation of the METTL3 enzyme.
The Role of METTL3 in Cellular Biology
METTL3 is the catalytic subunit of the methyltransferase complex responsible for adding m6A marks to messenger RNA (mRNA). This process is a fundamental layer of gene regulation, often referred to as epitranscriptomics. By marking specific RNA molecules, METTL3 helps determine the fate of those transcripts, including their stability and the rate at which they are converted into proteins. In healthy cells, this system ensures that gene expression is precisely tuned to the cell's needs. However, when this system is dysregulated, it can impact pathways related to cell growth, survival, and response to stress. Because of its central role in RNA metabolism, METTL3 has become a significant subject of study in oncology, particularly regarding how m6A modification patterns are altered in various types of cancer.
Research Associations and Evidence Strength
Recent studies have investigated the association between the rs1061026 variant and breast cancer susceptibility. Some research suggests that specific alleles of this SNP may be statistically linked to a reduced risk of breast cancer in certain populations. However, the evidence for this association is considered moderate and is often specific to certain ethnic groups or study cohorts. It is important to recognize that cancer development is a highly complex process involving numerous genetic, environmental, and lifestyle factors. A single SNP like rs1061026 is only one small factor in a vast biological landscape. Current findings are based on case-control studies, which are useful for identifying potential markers but do not establish a direct cause-and-effect relationship for any individual.
Interpreting Genetic Information
The frequency of the rs1061026 variant is known to be variable across different ethnic groups. If you have information about your genotype for this variant, it is important to understand that this does not constitute a medical diagnosis or a prediction of future health. Genetic associations identified in research studies are meant to help scientists understand biological mechanisms, not to guide individual medical care. There is no specific medication or clinical action associated with this variant. If you have concerns about breast cancer risk, the most appropriate step is to speak with a healthcare provider or a genetic counselor. They can assess your personal and family history to provide personalized screening recommendations and discuss evidence-based strategies for maintaining your health.
How common is this variant?
The frequency of the rs1061026 variant is variable across different ethnic groups, with distinct patterns of the T and G alleles observed in global populations.
Frequently asked questions
Does this variant mean I will develop breast cancer?
No. This variant is only associated with a statistical difference in risk in certain research studies. It is not a diagnostic test for cancer, and most people with any genotype for this variant will never develop the disease.
Can I use this information to change my cancer risk?
No. Genetic markers like this are not actionable for individual health management. You should focus on established health practices, such as regular screenings and consultations with your doctor, which are proven to be effective.
Is this a clinical test?
No, this is not a clinical diagnostic test. It is a research-based genetic marker and should not be used to make medical decisions or to assess your personal risk of cancer.
What should I do if I am worried about my risk?
If you are concerned about breast cancer risk, please consult a healthcare professional or a genetic counselor. They can evaluate your family history and personal health factors to provide appropriate medical advice.
Sources & further reading
Educational information only, last refreshed 11/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1061026?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29